These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5285376)

  • 21. Comparative pharmacokinetics of coumarin anticoagulants XLV: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin and phenylbutazone in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1980 Jan; 69(1):14-20. PubMed ID: 7354432
    [No Abstract]   [Full Text] [Related]  

  • 22. Retention data methods for the determination of drug-protein binding parameters by high-performance liquid chromatography.
    Sebille B; Thuaud N; Tillement JP
    J Chromatogr; 1981 Jan; 204():285-91. PubMed ID: 7217256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative interaction of warfarin and phenylbutazone with human serum albumin.
    Madsen BW; Ellis GM
    Biochem Pharmacol; 1981 Jun; 30(11):1169-73. PubMed ID: 7271816
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of trichloroethanol and metabolites and interconversions among variously referenced pharmacokinetic parameters.
    Garrett ER; Lambert HJ
    J Pharm Sci; 1973 Apr; 62(4):550-72. PubMed ID: 4698974
    [No Abstract]   [Full Text] [Related]  

  • 25. Competition between diftalone and other drugs for the binding site(s) on human serum albumin.
    Assandri A; Perazzi A
    Med Biol; 1976 Jun; 54(3):187-92. PubMed ID: 940363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
    He J; Shibukawa A; Tokunaga S; Nakagawa T
    J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
    Chan E; McLachlan AJ; Rowland M
    Chirality; 1993; 5(8):610-5. PubMed ID: 8305289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid method for the estimation of drug-albumin affinity constants in human plasma.
    Solomon HM; Thomas GB
    Clin Pharmacol Ther; 1971; 12(3):445-8. PubMed ID: 5567799
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to warfarin in hypothyroid rats.
    McIntosh ; Waters L; Fouts ; Wilson WR
    Eur J Pharmacol; 1971 Apr; 14(2):176-82. PubMed ID: 5164252
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of bile acids on the binding of drugs and dyes to human albumin.
    Bowmer CJ; Donoghue PG; Leong CF; Yates MS
    J Pharm Pharmacol; 1985 Nov; 37(11):812-5. PubMed ID: 2867164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin.
    Nagashima R; O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1969; 10(1):22-35. PubMed ID: 5765183
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).
    Breckenridge A; Orme ML; Thorgeirsson S; Davies DS; Brooks RV
    Clin Sci; 1971 Apr; 40(4):351-64. PubMed ID: 5575281
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction between warfarin and ethacrynic acid.
    Petrick RJ; Kronacher N; Alcena V
    JAMA; 1975 Feb; 231(8):843-4. PubMed ID: 1172754
    [No Abstract]   [Full Text] [Related]  

  • 35. Species differences in the effect of chloral hydrate on coumarin anticoagulants.
    Weiner M
    Ann N Y Acad Sci; 1971 Jul; 179():226-34. PubMed ID: 4105794
    [No Abstract]   [Full Text] [Related]  

  • 36. Consequences of the N-B transition of albumin for the binding of warfarin in human serum.
    van der Giesen WF; Wilting J
    Biochem Pharmacol; 1983 Jan; 32(2):281-5. PubMed ID: 6870956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the binding of coumarin anticoagulants and serum albumins.
    Garten S; Wosilait WD
    Biochem Pharmacol; 1971 Jul; 20(7):1661-8. PubMed ID: 4126702
    [No Abstract]   [Full Text] [Related]  

  • 38. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stopped-flow studies on drug-protein binding. Analog-computer analysis of the pH-dependent binding kinetics of warfarin and human serum albumin.
    Lassmann A; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):189-95. PubMed ID: 7121617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.